Transcriptional profiling of bone marrow stromal cells in response to Porphyromonas gingivalis secreted products

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Reddi, Durga ^a   Belibasakis, Georgios N ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; COLLAGENASE 3; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; CYCLOOXYGENASE 2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HAPTOGLOBIN; HEMOPEXIN; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 17; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E SYNTHASE; RANTES; SCATTER FACTOR; STROMELYSIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; VASCULOTROPIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE DESTRUCTION; BONE METABOLISM; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOGENIC BONE MARROW STROMAL CELL; PERIODONTITIS; PHENOTYPE; PORPHYROMONAS GINGIVALIS; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION PROFILING; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; PORPHYROMONAS GINGIVALIS; UP-REGULATION;

EID: 84865291387     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043899     Document Type: Article

References (114)

1. Yang H-W, Huang Y-F, Chou M-Y, (2004) Occurrence of Porphyromonas gingivalis and Tannerella forsythensis in Periodontally Diseased and Healthy Subjects. Journal of Periodontology 75: 1077-1083.
2. Van Winkelhoff AJ, Loos BG, Van Der Reijden WA, Van Der Velden U, (2002) Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction. Journal of Clinical Periodontology 29: 1023-1028.
3. Hajishengallis G, (2009) Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes and Infection 11: 637-645.
4. Bostanci N, Belibasakis GN, (2012) Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiology Letters 333: 1-9.
5. Hajishengallis G, Krauss JL, Liang S, McIntosh ML, Lambris JD, (2012) Advances in Experimental Medicine and Biology, 1. Current Topics in Innate Immunity II 946: 69-85.
6. Lamont RJ, Jenkinson HF, (1998) Life Below the Gum Line: Pathogenic Mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 62: 1244-1263.
7. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney JM, et al. (1992) Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. 1318-1324.
8. Okahashi N, Inaba H, Nakagawa I, Yamamura T, Kuboniwa M, et al. (2004) Porphyromonas gingivalis Induces Receptor Activator of NF-{kappa}B Ligand Expression in Osteoblasts through the Activator Protein 1 Pathway. Infect Immun 72: 1706-1714.
9. Reddi D, Bostanci N, Hashim A, Aduse-Opoku J, Curtis MA, et al. (2008) Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. Microbes and Infection 10: 1459-1468.
10. Reddi D, Brown SJ, Belibasakis GN, (2011) Porphyromonas gingivalis induces RANKL in bone marrow stromal cells: Involvement of the p38 MAPK. Microbial Pathogenesis 51: 415-420.
11. Ohno T, Okahashi N, Kawai S, Kato T, Inaba H, et al. (2006) Proinflammatory gene expression in mouse ST2 cell line in response to infection by Porphyromonas gingivalis. Microbes and Infection 8: 1025-1034.
12. Ohno T, Okahashi N, Morisaki I, Amano A, (2008) Signaling pathways in osteoblast proinflammatory responses to infection by Porphyromonas gingivalis. Oral Microbiology and Immunology 23: 96-104.
13. Imatani T, Kato T, Okuda K, Yamashita Y, (2004) Histatin 5 inhibits apoptosis in human gingival fibroblasts induced by porphyromonas gingivalis cell-surface polysaccharide. European Journal Of Medical Research 9: 528-532.
14. Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, et al. (2007) Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiology Letters 272: 106-113.
15. Stathopoulou P, Galicia J, Benakanakere M, Garcia C, Potempa J, et al. (2009) Porphyromonas gingivalis induce apoptosis in human gingival epithelial cells through a gingipain-dependent mechanism. BMC Microbiology 9: 107.
16. Kato T, Tsuda T, Inaba H, Kawai S, Okahashi N, et al. (2008) Porphyromonas gingivalis gingipains cause G1 arrest in osteoblastic/stromal cells. Oral Microbiology and Immunology 23: 158-164.
17. Inaba H, Kuboniwa M, Bainbridge B, Yilmaz Ö, Katz J, et al. (2009) Porphyromonas gingivalis invades human trophoblasts and inhibits proliferation by inducing G1 arrest and apoptosis. Cellular Microbiology 11: 1517-1532.
18. Kang I-C, Kuramitsu HK, (2002) Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunology & Medical Microbiology 34: 311-317.
19. Jiang Y, Graves DT, (1999) Periodontal Pathogens Stimulate CC-Chemokine Production by Mononuclear and Bone-Derived Cells. Journal of Periodontology 70: 1472-1478.
20. Garlet GP, Martins W, Ferreira BR, Milanezi CM, Silva JS, (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. Journal of Periodontal Research 38: 210-217.
21. Zhou Q, Desta T, Fenton M, Graves DT, Amar S, (2005) Cytokine Profiling of Macrophages Exposed to Porphyromonas gingivalis, Its Lipopolysaccharide, or Its FimA Protein. Infection and Immunity 73: 935-943.
22. Laflamme C, Rouabhia M, Le X (2009) Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. 141-149 p.
23. Bostanci N, Allaker R, Johansson U, Rangarajan M, Curtis MA, et al. (2007) Interleukin-1alpha; stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. Oral Microbiology and Immunology 22: 52-60.
24. Liu Y-CG, Lerner UH, Teng Y-TA, (2010) Cytokine responses against periodontal infection: protective and destructive roles. Periodontology 2000 52: 163-206.
25. Belibasakis GN, Bostanci N, Hashim A, Johansson A, Aduse-Opoku J, et al. (2007) Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: A putative role of the Arg-gingipains. Microbial Pathogenesis 43: 46-53.
26. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, et al. (2006) B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal Disease. The American Journal of Pathology 169: 987-998.
27. Belibasakis GN, Reddi D, Bostanci N, (2011) Porphyromonas gingivalis Induces RANKL in T-cells. Inflammation 34: 133-138.
28. Offenbacher S, (1996) Periodontal diseases: pathogenesis. Annals of Periodontology 1: 821-878.
29. Noguchi K, Ishikawa I, (2007) The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontology 2000 43: 85-101.
30. Choi B-K, Moon S-Y, Cha J-H, Kim K-W, Yoo Y-J, (2005) Prostaglandin E2 Is a Main Mediator in Receptor Activator of Nuclear Factor-kappaB Ligand-Dependent Osteoclastogenesis Induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. Journal of Periodontology 76: 813-820.
31. Tolosano E, Fagoonee S, Hirsch E, Berger FG, Baumann H, et al. (2002) Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 100: 4201-4208.
32. Ebersole JL, Machen RL, Steffen MJ, DE W, (1997) Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clinical and experimental immunology 107: 347-352.
33. Bramanti TE, Holt SC, (1991) oles of porphyrins and host iron transport proteins in regulation of growth of Porphyromonas gingivalis W50. Journal of Bacteriology 173: 7330-7339.
34. Sroka A, Sztukowska M, Potempa J, Travis J, Genco CA, (2001) Degradation of Host Heme Proteins by Lysine- and Arginine-Specific Cysteine Proteinases (Gingipains) ofPorphyromonas gingivalis. Journal of Bacteriology 183: 5609-5616.
35. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, et al. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921.
36. Olczak T, Simpson W, Liu X, CA G, (2005) Iron and heme utilization in Porphyromonas gingivalis. FEMS Microbiol Rev 29: 119-144.
37. Wojaczyński J, Wójtowicz H, Bielecki M, Olczak M, Smalley JW, et al. (2011) Iron(III) mesoporphyrin IX and iron(III) deuteroporphyrin IX bind to the Porphyromonas gingivalis HmuY hemophore. Biochemical and Biophysical Research Communications 411: 299-304.
38. Gao J-L, Nguyen K-A, Hunter N, (2010) Characterization of a Hemophore-like Protein from Porphyromonas gingivalis. Journal of Biological Chemistry 285: 40028-40038.
39. Kluve-Beckerman B, Drumm ML, MD B, (1991) Nonexpression of the human serum amyloid A three (SAA3) gene. DNA and Cell Biology 10: 651-665.
40. Reigstad CS, Bäckhed FF, (2010) Microbial regulation of SAA3 expression in mouse colon and adipose tissue. Gut Microbes 1: 55-57.
41. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, et al. (2007) Natural history and outcome in systemic AA amyloidosis. The New England journal of medicine 356: 2361-2371.
42. Khoury S, Dusek JJ, Anderson GB, Vigneswaran N, (2004) Systemic amyloidosis manifesting as localized, severe periodontitis. The Journal of the American Dental Association 135: 617-623.
43. Cengiz MI, Wang HL, Levent Y, (2010) Oral involvement in a case of AA amyloidosis: a case report. Journal of medical case reports 4: 200.
44. Glurich I, Grossi S, Albini B, Ho A, Shah R, et al. (2002) Systemic Inflammation in Cardiovascular and Periodontal Disease: Comparative Study. Clinical and Diagnostic Laboratory Immunology 9: 425-432.
45. Bals R, Wilson JM, (2003) Cathelicidins- a family of multifunctional antimicrobial peptides. Cellular and Molecular Life Sciences 60: 711-720.
46. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, et al. (2010) Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37. STEM CELLS 28: 2229-2238.
47. Altman H, Steinberg D, Porat Y, Mor A, Fridman D, et al. (2006) In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. Journal of Antimicrobial Chemotherapy 58: 198-201.
48. Bachrach G, Altman H, Kolenbrander PE, Chalmers NI, Gabai-Gutner M, et al. (2008) Resistance of Porphyromonas gingivalis ATCC 33277 to Direct Killing by Antimicrobial Peptides Is Protease Independent. Antimicrobial Agents and Chemotherapy 52: 638-642.
49. Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, et al. (1992) Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. Journal of Biological Chemistry 267: 18902-18907.
50. Potempa J, Banbula A, Travis J, (2000) Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontology 2000 24: 153-192.
51. Popadiak K, Potempa J, Riesbeck K, Blom AM, (2007) Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. The Journal of Immunology 178: 7242-7250.
52. Grenier D, Roy S, Chandad F, Plamondon P, Yoshioka M, et al. (2003) Effect of Inactivation of the Arg- and/or Lys-Gingipain Gene on Selected Virulence and Physiological Properties of Porphyromonas gingivalis. Infection and Immunity 71: 4742-4748.
53. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, et al. (2010) The C5a Receptor Impairs IL-12-Dependent Clearance of Porphyromonas gingivalis and Is Required for Induction of Periodontal Bone Loss. The Journal of Immunology 186: 869-877.
54. Krauss JL, Potempa J, Lambris JD, Hajishengallis G, (2010) Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontology 2000 52: 141-162.
55. Guo Y, Nguyen K-A, Potempa J, (2010) Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontology 2000 54: 15-44.
56. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, et al. (2010) Microbial Hijacking of Complement-Toll-Like Receptor Crosstalk. Sci Signal 3: ra11-.
57. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, et al. (2011) Low-Abundance Biofilm Species Orchestrates Inflammatory Periodontal Disease through the Commensal Microbiota and Complement. Cell host & microbe 10: 497-506.
58. Ortega-Hernandez O-D, Bassi N, Shoenfeld Y, Anaya J-M, (2009) The Long Pentraxin 3 and Its Role in Autoimmunity. Seminars in Arthritis and Rheumatism 39: 38-54.
59. Pradeep AR, Kathariya R, Raghavendra NM, Sharma A, (2011) Levels of Pentraxin-3 in Gingival Crevicular Fluid and Plasma in Periodontal Health and Disease. Journal of Periodontology 82: 734-741.
60. Fujita Y, Ito H, Sekino S, Numabe Y (2011) Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Odontology: 1-7.
61. Zhou Q, Amar S, (2007) Identification of Signaling Pathways in Macrophage Exposed to Porphyromonas gingivalis or to Its Purified Cell Wall Components. The Journal of Immunology 179: 7777-7790.
62. Katagiri T, Takahashi N, (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Diseases 8: 147-159.
63. Johnson RB, Serio FG, Dai X, (1999) Vascular Endothelial Growth Factors and Progression of Periodontal Diseases. Journal of Periodontology 70: 848-852.
64. Prapulla DV, Sujatha PB, Pradeep AR, (2007) Gingival Crevicular Fluid VEGF Levels in Periodontal Health and Disease. Journal of Periodontology 78: 1783-1787.
65. Suthin K, Matsushita K, Machigashira M, Tatsuyama S, Imamura T, et al. (2003) Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingival fibroblasts. Journal of Periodontal Research 38: 90-96.
66. Bostanci N, Reddi D, Rangarajan M, Curtis MA, Belibasakis GN, (2009) Porphyromonas gingivalis stimulates TACE production by T cells. Oral Microbiology and Immunology 24: 146-151.
67. Leto G, Crescimanno M, Flandina C, Sepporta M, Tumminello F, (2011) Cathepsin L in Normal and Pathological Bone Remodeling. Clinical Reviews in Bone and Mineral Metabolism 9: 107-121.
68. Dickinson DP, (2002) Cysteine Peptidases of Mammals: Their Biological Roles and Potential Effects in the Oral Cavity and Other Tissues in Health and Disease. Critical Reviews in Oral Biology & Medicine 13: 238-275.
69. Palcanis KG, Lariava IK, Wells BR, Suggs KA, Landis JR, et al. (1992) Elastase as an Indicator of Periodontal Disease Progression. Journal of Periodontology 63: 237-242.
70. Armitage GC, Jeffcoat MK, Chadwick DE, Taggart EJ, Numabe Y, et al. (1994) Longitudinal Evaluation of Elastase as a Marker for the Progression of Periodontitis. Journal of Periodontology 65: 120-128.
71. Jin LJ, Söder P-Ö, Åsman B, Söder B, Purlene A, et al. (1995) Variations in crevicular fluid elastase levels in periodontitis patients on long-term maintenance. European Journal of Oral Sciences 103: 84-89.
72. Stetler G, Brewer MT, Thompson RC, (1986) Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Research 14: 7883-7896.
73. Laugisch O, Schacht M, Guentsch A, Kantyka T, Sroka A, et al. (2011) Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid. Molecular Oral Microbiology 27: 45-56.
74. Kretschmar S, Yin L, Roberts F, London R, Flemmig TT, et al. (2011) Protease inhibitor levels in periodontal health and disease. Journal of Periodontal Research 47: 228-235.
75. Into T, Inomata M, Kanno Y, Matsuyama T, Machigashira M, et al. (2006) Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue. Clinical & Experimental Immunology 145: 545-554.
76. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, et al. (2001) The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins. Journal of Biological Chemistry 276: 33293-33296.
77. Nakata K, Yamasaki M, Iwata T, Suzuki K, Nakane A, et al. (2000) Anaerobic Bacterial Extracts Influence Production of Matrix Metalloproteinases and Their Inhibitors by Human Dental Pulp Cells. Journal of endodontics 26: 410-413.
78. Chang Y-C, Lai C-C, Yang S-F, Chan Y, Hsieh Y-S, (2002) Stimulation of Matrix Metalloproteinases by Black-Pigmented Bacteroides in Human Pulp and Periodontal Ligament Cell Cultures. Journal of endodontics 28: 90-93.
79. Pattamapun K, Tiranathanagul S, Yongchaitrakul T, Kuwatanasuchat J, Pavasant P, (2003) Activation of MMP-2 by Porphyromonas gingivalis in human periodontal ligament cells. Journal of Periodontal Research 38: 115-121.
80. Zhou J, Windsor LJ, (2006) Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases. Journal of Periodontal Research 41: 47-54.
81. Hernandez M, Valenzuela MA, Lopez-Otin C, Alvarez Js, Lopez JM, et al. (2006) Matrix Metalloproteinase-13 Is Highly Expressed in Destructive Periodontal Disease Activity. Journal of Periodontology 77: 1863-1870.
82. Hernández M, Martínez B, Tejerina JM, Valenzuela MA, Gamonal J, (2007) MMP-13 and TIMP-1 determinations in progressive chronic periodontitis. Journal of Clinical Periodontology 34: 729-735.
83. Rai B, Kharb S, Jain R, Anand SC, (2008) Biomarkers of periodontitis in oral fluids. Journal of Oral Science 50: 53-56.
84. Balwant R, Jasdeep K, Rajnish J, Anand SC, (2010) Levels of gingival crevicular metalloproteinases-8 and-9 in periodontitis. The Saudi Dental Journal 22: 129-131.
85. Oyarzún A, Arancibia R, Hidalgo R, Peñafiel C, Cáceres M, et al. (2010) Involvement of MT1-MMP and TIMP-2 in human periodontal disease. Oral Diseases 16: 388-395.
86. Silva N, Dutzan N, Hernandez M, Dezerega A, Rivera O, et al. (2008) Characterization of progressive periodontal lesions in chronic periodontitis patients: levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. Journal of Clinical Periodontology 35: 206-214.
87. Grenier D, Mayrand D, (2001) Inactivation of tissue inhibitor of metalloproteinases-1 (TIMP-1) by Porphyromonas gingivalis. FEMS microbiology letters 203: 161-164.
88. Asai Y, Ohyama Y, Gen K, Ogawa T, (2001) Bacterial Fimbriae and Their Peptides Activate Human Gingival Epithelial Cells through Toll-Like Receptor 2. Infection and Immunity 69: 7387-7395.
89. Nociti FH Jr, Foster BL, Barros SP, Darveau RP, Somerman MJ, (2004) Cementoblast Gene Expression is Regulated by Porphyromonas gingivalis Lipopolysaccharide Partially via Toll-like Receptor-4/MD-2. J Dent Res 83: 602-607.
90. Nemoto E, Darveau RP, Foster BL, Nogueira-Filho GR, Somerman MJ, (2006) Regulation of Cementoblast Function by P. gingivalis Lipopolysaccharide via. TLR2: 733-738.
91. Reife RA, Coats SR, Al-Qutub M, Dixon DM, Braham PA, et al. (2006) Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition. Cellular Microbiology 8: 857-868.
92. Sawada N, Ogawa T, Asai Y, Makimura Y, Sugiyama A, (2007) Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis. Clinical & Experimental Immunology 148: 529-536.
93. Brozovic S, Sahoo R, Barve S, Shiba H, Uriarte S, et al. (2006) Porphyromonas gingivalis enhances FasL expression via up-regulation of NFkB-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells. Microbiology 152: 797-806.
94. Hajishengallis G, Tapping RI, Harokopakis E, Nishiyama S-i, Ratti P, et al. (2006) Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cellular Microbiology 8: 1557-1570.
95. Burns E, Bachrach G, Shapira L, Nussbaum G, (2006) Cutting Edge: TLR2 Is Required for the Innate Response to Porphyromonas gingivalis: Activation Leads to Bacterial Persistence and TLR2 Deficiency Attenuates Induced Alveolar Bone Resorption. The Journal of Immunology 177: 8296-8300.
96. Rawlings JS, Rosler KM, Harrison DA, (2004) The JAK/STAT signaling pathway. Journal of Cell Science 117: 1281-1283.
97. O'Shea JJ, Gadina M, Schreiber RD, (2002) Cytokine Signaling in 2002: New Surprises in the Jak/Stat Pathway. Cell 109: S121-S131.
98. Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, et al. (2007) Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cellular Microbiology 9: 1997-2007.
99. Zhou Q, Amar S, (2006) Identification of Proteins Differentially Expressed in Human Monocytes Exposed to Porphyromonas gingivalis and Its Purified Components by High-Throughput Immunoblotting. Infection and Immunity 74: 1204-1214.
100. O'Brien CA, Gubrij I, Lin S-C, Saylors RL, Manolagas SC, (1999) STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone. Journal of Biological Chemistry 274: 19301-19308.
101. Bishop KA, Meyer MB, Pike JW, (2009) A Novel Distal Enhancer Mediates Cytokine Induction of Mouse Rankl Gene Expression. Molecular Endocrinology 23: 2095-2110.
102. Mori T, Miyamoto T, Yoshida H, Asakawa M, Kawasumi M, et al. (2011) IL-1b and TNFa-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. International Immunology 23: 701-712.
103. Zanotti S, Stadmeyer L, Smerdel-Ramoya A, Durant D, Canalis E, (2009) Misexpression of CCAAT/enhancer binding protein beta causes osteopenia. Journal of Endocrinology 201: 263-274.
104. Ng PK-S, Tsui SK-W, Lau CP-Y, Wong C-H, Wong WH-T, et al. (2010) CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression. Journal of Cellular Biochemistry 110: 438-446.
105. Zamurovic N, Cappellen D, Rohner D, Susa M, (2004) Coordinated Activation of Notch, Wnt, and Transforming Growth Factor-β Signaling Pathways in Bone Morphogenic Protein 2-induced Osteogenesis. Journal of Biological Chemistry 279: 37704-37715.
106. Xing Q, Ye Q, Fan M, Zhou Y, Xu Q, et al. (2010) Porphyromonas gingivalis lipopolysaccharide inhibits the osteoblastic differentiation of preosteoblasts by activating Notch1 signaling. Journal of Cellular Physiology 225: 106-114.
107. Hayden MS, Ghosh S, (2012) NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes & Development 26: 203-234.
108. Arabaci T, Cicek Y, Canakci V, Canakci CF, Ozgoz M, et al. (2010) Immunohistochemical and Stereologic Analysis of NF-κB Activation in Chronic Periodontitis. European Journal of Dentistry 4: 454-461.
109. Sun Z, Andersson R, (2002) NF-kB Activation and Inhibition: A Review. Shock 18: 99-106.
110. Choi E-K, Park S-A, Oh W-M, Kang H-C, Kuramitsu HK, et al. (2005) Mechanisms of Porphyromonas gingivalis-induced monocyte chemoattractant protein-1 expression in endothelial cells. FEMS Immunology & Medical Microbiology 44: 51-58.
111. Walter C, Zahlten J, Schmeck B, Schaudinn C, Hippenstiel S, et al. (2004) Porphyromonas gingivalis Strain-Dependent Activation of Human Endothelial Cells. Infection and Immunity 72: 5910-5918.
112. Zhang D, Zheng H, Zhao J, Lin L, Li C, et al. (2011) Porphorymonas gingivalis induces intracellular adhesion molecule-1 expression in endothelial cells through the nuclear factor-kappaB pathway, but not through the p38 MAPK pathway. Journal of Periodontal Research 46: 31-38.
113. Yanti, Lee M, Kim D, Hwang J-K, (2009) Inhibitory Effect of Panduratin A on c-Jun N-Terminal Kinase and Activator Protein-1 Signaling Involved in Porphyromonas gingivalis Supernatant-Stimulated Matrix Metalloproteinase-9 Expression in Human Oral Epidermoid Cells. Biological and Pharmaceutical Bulletin 32: 1770-1775.
114. Wong ML, Medrano JF, (2005) Real-time PCR for mRNA quantitation. Biotechniques 39: 75-85.